<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://pharmactu.fr/articles/prac-ema-fer-injectable-hypophosphatemie-osteomalacie-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Pharmactu</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-09-09T07:34:00+02:00</news:publication_date>
      <news:title>Fer injectable : l&apos;EMA ouvre une revue sur le risque d&apos;hypophosphatémie</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmactu.fr/articles/eskazole-albendazole-circuit-officine-ferme-retrocession-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Pharmactu</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-09-09T07:11:00+02:00</news:publication_date>
      <news:title>Eskazole 400 mg : le circuit officine est fermé, accès par rétrocession seulement</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmactu.fr/articles/victan-2mg-rupture-loflazepate-benzodiazepine-2027</loc>
    <news:news>
      <news:publication>
        <news:name>Pharmactu</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-09-08T07:16:00+02:00</news:publication_date>
      <news:title>Victan 2 mg : rupture jusqu&apos;au premier trimestre 2027</news:title>
    </news:news>
  </url>
</urlset>
